# Treatment Options for Myotonic Dystrophy
The treatment of myotonic dystrophy focuses on relieving symptoms and preventing complications, since there is currently no medication that addresses the underlying genetic defect. The approach differs depending on the stage of the disease and the individual, based on which symptoms are most prominent.
Medications for Myotonia
**Quinidine and Mexiletine**
ProveniIncluded in official guidelines, or approved by EMA or FDA
These medications are used to reduce myotonia (muscle tension and stiffness). They work by slowing down electrical activity in the muscles, allowing them to relax more quickly after contraction. Quinidine has been in use for a long time; mexiletine is a newer variant that is often better tolerated.
Known side effects include gastrointestinal problems, dizziness, and in rare cases, heart rhythm disturbances. For this reason, heart rhythm is regularly monitored before and during treatment.
Physiotherapy and Movement Training
**Muscle Training and Activity**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular movement and targeted muscle training help maintain muscle strength and endurance. It works best when the exercises are tailored and continuously adjusted to what the person can manage. This does not prevent the muscles from gradually weakening, but it slows down the process and keeps joints flexible.
An important point is that exertion is not harmful, but caution is advised: overexertion can be counterproductive. Physiotherapists with knowledge of myotonic dystrophy can help find a balance.
Treatment of Fatigue
**Energy Management and Occupational Therapy**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Many people with myotonic dystrophy struggle with severe fatigue that does not go away with rest. Occupational therapists help distribute energy better throughout the day and manage energy-draining activities differently. This probably cannot completely eliminate the fatigue, but it can sometimes make daily life considerably easier.
Some recent studies suggest that energy expenditure in the body in myotonic dystrophy is abnormal, which may partly explain the fatigue. This is still a subject of research.
Heart and Lung Monitoring
**Heart Monitoring and Lung Function Tests**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Because myotonic dystrophy can affect heart muscle tissue and breathing muscles, heart rhythm disturbances and lung function are monitored at regular intervals. This can be done with an electrocardiogram (ECG), sometimes with a Holter monitor (24-hour heart monitoring), and lung function tests.
If disturbances are found, devices such as a pacemaker may be necessary. This is especially important because people with myotonic dystrophy have an increased risk of sudden rhythm disturbances.
Gastrointestinal Problems
**Nutritional Advice and Digestive Medications**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Esophageal and gastrointestinal disorders are very common in myotonic dystrophy and can be burdensome. A dietitian can help adjust the diet (for example, more frequent small meals, more fluid intake, avoiding certain foods). Medications can help with acid reflux, constipation, or slow gastric transit.
Recent research emphasizes that these complaints contribute significantly to the burden of daily life and deserve more attention.
Airway Hygiene and Breathing
**Respiratory Physiotherapy and Sleep Monitoring**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Because breathing muscles can weaken, especially at night, screening for sleep apnea and shallow breathing is performed. Breathing exercises and cough assistance can help keep the airways clear and prevent infections.
In case of severe weakness, home ventilation at night may be necessary. This does not prevent the muscles from weakening, but it helps maintain normal oxygen levels and improve sleep quality.
Experimental Treatments Under Investigation
**Antisense Oligonucleotides (ASO)**
ResearchediPositive results in clinical studies, not yet standard treatment
Various antisense therapies are currently being investigated in clinical trials. These medications are designed to counter the misshapen protein (produced by the genetic repeat) or to restore normal gene splicing. Some examples under investigation include zeleicitam basivarsen (DYNE-101) and other splicing modulators.
These approaches directly target the genetic mechanism and appear promising in laboratory and animal models, but are not yet routinely available outside research programs.
**Medications for myotonia**
ResearchediPositive results in clinical studies, not yet standard treatment
Recent research suggests that eliminating myotonia alone may help reduce the underlying muscle weakness mechanism. Other experimental approaches (such as HSP90 inhibitors) focus on protein folding and can positively influence alternative splicing.
**Nutritional interventions**
ResearchediPositive results in clinical studies, not yet standard treatment
Some natural substances (for example from bitter melons) show promising effects on muscle function in research conditions, with possible differences between men and women. It is far too early to recommend this, but research is ongoing.
Supportive care
**Speech therapy and swallowing physiotherapy**
ProveniIncluded in official guidelines, or approved by EMA or FDA
In muscle weakness affecting speech or swallowing, speech therapy makes communication clearer and swallowing safer. This does not prevent the underlying weakness, but minimizes the risk of nutritional problems and aspiration.
**Mental health and social work**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Living with a progressive muscle disease can be emotionally heavy. Psychotherapists, psychiatrists and social workers help cope with grief, depression and uncertainty, and help solve practical problems (such as working conditions or finances).
Collaboration and preparation
A multidisciplinary team — neurologist, physiotherapist, cardiologist, pulmonologist, ophthalmologist and others — works together to monitor all aspects of the disease. As the disease progresses, conversations about future care (such as ventilation or resuscitation) may become important. This is best prepared for when there is still time and clarity.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._